Nuvectis Pharma
(NASDAQ) NVCT
Nuvectis Pharma Financials at a Glance
Market Cap
$217.76M
Revenue (TTM)
$0.00
Net Income (TTM)
$26.44M
EPS (TTM)
$-1.28
P/E Ratio
-6.40
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$8.19
Volume
710
Open
$8.21
Price
$8.19
Volume
710
Open
$8.21
Previous Close
$8.19
Daily Range
$8.08 - $8.21
52-Week Range
$5.55 - $11.52
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$8.19
Volume
710
Open
$8.21
Previous Close
$8.19
Daily Range
$8.08 - $8.21
52-Week Range
$5.55 - $11.52
NVCT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nuvectis Pharma
Industry
Biotechnology
Sector
Health CareEmployees
13
CEO
Ronald E. Bentsur, MBA
Website
www.nuvectis.comHeadquarters
Fort Lee, NJ 07024, US
NVCT Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-205%
Return on Capital
-1%
Return on Assets
-83%
Earnings Yield
-15.63%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$217.76M
Shares Outstanding
26.49M
Volume
710
Short Interest
0.00%
Avg. Volume
57.78K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$27.57M
EBITDA
$27.57M
Operating Cash Flow
$16.01M
Capital Expenditure
$0.00
Free Cash Flow
$16.01M
Cash & ST Invst.
$31.63M
Total Debt
$0.00
Nuvectis Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$217.76M
N/A
Market Cap/Employee
$16.75M
N/A
Employees
13
N/A
Net Income
$7.31M
-17.1%
EBITDA
$8.21M
-27.3%
Quarterly Fundamentals
Net Cash
$31.63M
+70.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-83.39%
N/A
Return on Invested Capital
-1.50%
N/A
Free Cash Flow
$3.97M
-61.2%
Operating Cash Flow
$3.97M
-61.2%